Technetium 99M Market Size

Global Technetium 99M Market size was valued at USD 6,482.4 Million in 2025 and is expected to reach at USD  10,122.5 Million by 2034 at a CAGR of 5.02% during the forecast period 2025 – 2034.

Technetium 99M Market Overview

Technetium 99M is a silver-gray, radioactive metal. Technetium is found in minimal quantities in the earth’s crust but is primarily anthropogenic. Technetium 99M is manufactured during nuclear reactor operations and is a byproduct of the various nuclear weapons explosions. Technetium-99 can be found as a component of nuclear waste.

Various factors, such as the increasing prevalence of chronic diseases, increasing investment in the new healthcare facilities, increasing demand for the nuclear medicinal technologies, technological advancements in the technetium 99M production, are mainly driving the market growth of this region.

However, factors such as the availability of substitutes, high cost of the technetium 99M mining, stringent regulatory framework, and lack of universal directives pertaining to the usage and production of the technetium are mainly restraining the market growth of this region.

The global Technetium 99M market is segmented by production method, by formulation type, by isotopic services, by application, by end users and by region. By formulation type, the market is segmented into the radiopharmaceuticals, diagnostic imaging agents and therapeutic agents.

Among all of these, radio pharmaceutical segment held highest market share in 2024 and is expected to keep its dominance during the forecast period. Radiopharmaceuticals are radioactive drugs, which are used to diagnose and treat various medical conditions.

By application, the technetium 99M market is segmented into cardiovascular, bone scan, respiratory and tumor imaging and others. Among all of these, cardiovascular segments held the highest market share in 2024 and are expected to keep their dominance during the forecast period.

By end user, the global technetium market is segmented into hospitals, diagnostic centers and others. Among all of these, hospitals held the highest market share in 2024 and are expected to keep its dominance during the forecast period owing to the increasing number of government hospitals and increasing investment in the new healthcare facilities by private companies.

By region, the Technetium 99M market is segmented into North America, Asia Pacific, Europe, the Middle East & Africa, and Latin America.  By Region, North America held the highest market share in 2024 and is expected to keep its dominance during the forecast period owing to the presence of the major market players and rapidly expanding healthcare industry in the region. The major countries such as the U.S., Canada, and Mexico are mainly driving the market growth of this region.

Report Scope

Feature of the Report Details
Market Size in 2025 USD 6,482.4 Million
Projected Market Size in 2034 USD 10,122.5 Million
Market Size in 2024 USD 6,200 Million
CAGR Growth Rate 5.02% CAGR
Base Year 2024
Forecast Period 2025-2034
Key Segment By Production Method, Formulation Type, Isotopic Services, Application, End User and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options Request tailored purchasing options to fulfil your requirements for research.

CMI has comprehensively analyzed the Global Technetium 99M Market. The driving forces, restraints, challenges, opportunities, and key trends have been explained in depth to depict in depth the scenario of the market. Segment wise market size and market share during the forecast period are duly addressed to portray the probable picture of this global Technetium 99M industry.

The competitive landscape includes key innovators, aftermarket service providers, market giants as well as niche players who are studied and analyzed extensively with respect to their strengths and weaknesses as well as value addition prospects. In addition, this report covers key players’ profiling, market shares, mergers and acquisitions, consequent market fragmentation, new trends and dynamics in partnerships.

List of the prominent players in the Technetium 99M Market:

  • Advanced Cyclotron Systems Inc
  • Bayer AG
  • GE Healthcare Philips Healthcare (Koninklijke Philips N.V.)
  • Siemens
  • Eckert & Ziegler
  • IBA Radiopharma Solutions
  • Medi-Radiopharma Kft.
  • Lantheus Holdings Inc.
  • Nordion Inc.
  • Sumitomo Heavy Industries Ltd.
  • NTP Radioisotopes SOC Ltd
  • Isotope JSC
  • Jubilant Life Sciences
  • China lsotope & Radiation Corporation
  • SDS Lifesciences Pvt. Ltd.
  • BWX Technologies Inc.
  • Others

The Technetium 99M Market is segmented as follows:

By Production Method

  • Generator
  • Cyclotron
  • Nuclear Reactor

By Formulation Type

  • Radiopharmaceuticals
  • Diagnostic Imaging Agents
  • Therapeutic Agents

By Isotopic Services  

  • Gamma Camera
  • Single Photon Emission Computed Tomography (SPECT)

By Application           

  • Cardiovascular
  • Bone Scan
  • Respiratory
  • Tumour Imaging
  • Others

By End User   

  • Hospitals
  • Diagnostic Centers
  • Others

Regional Coverage:

North America

  • U.S.
  • Canada
  • Mexico
  • Rest of North America

Europe

  • Germany
  • France
  • U.K.
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • New Zealand
  • Australia
  • South Korea
  • Taiwan
  • Rest of Asia Pacific

The Middle East & Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America